Table of Content

Table of Contents
Table of Contents
1 Industry Overview
1.1 IBS-C Drugs Industry
Figure IBS-C Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of IBS-C Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of IBS-C Drugs
1.2.2 Downstream
Table Application Segment of IBS-C Drugs
Table Global IBS-C Drugs Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 IBS-C Drugs Market by Type
3.1 By Type
3.1.1 Linaclotide 
Table Major Company List of Linaclotide 
3.1.2 Lubiprostone 
Table Major Company List of Lubiprostone 
3.1.3 Osmotic Laxatives 
Table Major Company List of Osmotic Laxatives 
3.1.4 Stimulant Laxatives 
Table Major Company List of Stimulant Laxatives 
3.1.5 Others
Table Major Company List of Others
3.2 Market Size
Table Global IBS-C Drugs Market 2016-2020, by Type, in USD Million
Figure Global IBS-C Drugs Market Growth 2016-2020, by Type, in USD Million
Table Global IBS-C Drugs Market 2016-2020, by Type, in Volume
Figure Global IBS-C Drugs Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global IBS-C Drugs Market Forecast 2021-2026, by Type, in USD Million
Table Global IBS-C Drugs Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Catalent Pharmaceuticals Solutions  (Company Profile, Sales Data etc.)
4.1.1 Catalent Pharmaceuticals Solutions  Profile
Table Catalent Pharmaceuticals Solutions  Overview List
4.1.2 Catalent Pharmaceuticals Solutions  Products & Services
4.1.3 Catalent Pharmaceuticals Solutions  Business Operation Conditions
Table Business Operation of Catalent Pharmaceuticals Solutions  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Nestle  (Company Profile, Sales Data etc.)
4.2.1 Nestle  Profile
Table Nestle  Overview List
4.2.2 Nestle  Products & Services
4.2.3 Nestle  Business Operation Conditions
Table Business Operation of Nestle  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Abbott Laboratories  (Company Profile, Sales Data etc.)
4.3.1 Abbott Laboratories  Profile
Table Abbott Laboratories  Overview List
4.3.2 Abbott Laboratories  Products & Services
4.3.3 Abbott Laboratories  Business Operation Conditions
Table Business Operation of Abbott Laboratories  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Synergy Pharmaceuticals  (Company Profile, Sales Data etc.)
4.4.1 Synergy Pharmaceuticals  Profile
Table Synergy Pharmaceuticals  Overview List
4.4.2 Synergy Pharmaceuticals  Products & Services
4.4.3 Synergy Pharmaceuticals  Business Operation Conditions
Table Business Operation of Synergy Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Sucampo Pharmaceuticals  (Company Profile, Sales Data etc.)
4.5.1 Sucampo Pharmaceuticals  Profile
Table Sucampo Pharmaceuticals  Overview List
4.5.2 Sucampo Pharmaceuticals  Products & Services
4.5.3 Sucampo Pharmaceuticals  Business Operation Conditions
Table Business Operation of Sucampo Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Novartis Pharma Ag  (Company Profile, Sales Data etc.)
4.6.1 Novartis Pharma Ag  Profile
Table Novartis Pharma Ag  Overview List
4.6.2 Novartis Pharma Ag  Products & Services
4.6.3 Novartis Pharma Ag  Business Operation Conditions
Table Business Operation of Novartis Pharma Ag  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Astellas Pharmaceuticals  (Company Profile, Sales Data etc.)
4.7.1 Astellas Pharmaceuticals  Profile
Table Astellas Pharmaceuticals  Overview List
4.7.2 Astellas Pharmaceuticals  Products & Services
4.7.3 Astellas Pharmaceuticals  Business Operation Conditions
Table Business Operation of Astellas Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Ardelyx, Inc  (Company Profile, Sales Data etc.)
4.8.1 Ardelyx, Inc  Profile
Table Ardelyx, Inc  Overview List
4.8.2 Ardelyx, Inc  Products & Services
4.8.3 Ardelyx, Inc  Business Operation Conditions
Table Business Operation of Ardelyx, Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Synthetic Biologics, Inc  (Company Profile, Sales Data etc.)
4.9.1 Synthetic Biologics, Inc  Profile
Table Synthetic Biologics, Inc  Overview List
4.9.2 Synthetic Biologics, Inc  Products & Services
4.9.3 Synthetic Biologics, Inc  Business Operation Conditions
Table Business Operation of Synthetic Biologics, Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Teva Pharmaceutical Industries  (Company Profile, Sales Data etc.)
4.10.1 Teva Pharmaceutical Industries  Profile
Table Teva Pharmaceutical Industries  Overview List
4.10.2 Teva Pharmaceutical Industries  Products & Services
4.10.3 Teva Pharmaceutical Industries  Business Operation Conditions
Table Business Operation of Teva Pharmaceutical Industries  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Bama-Geve, SLU  (Company Profile, Sales Data etc.)
4.11.1 Bama-Geve, SLU  Profile
Table Bama-Geve, SLU  Overview List
4.11.2 Bama-Geve, SLU  Products & Services
4.11.3 Bama-Geve, SLU  Business Operation Conditions
Table Business Operation of Bama-Geve, SLU  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Ferring BV  (Company Profile, Sales Data etc.)
4.12.1 Ferring BV  Profile
Table Ferring BV  Overview List
4.12.2 Ferring BV  Products & Services
4.12.3 Ferring BV  Business Operation Conditions
Table Business Operation of Ferring BV  (Sales Revenue, Cost, Gross Margin)
4.13 Ironwood Pharmaceuticals, Inc  (Company Profile, Sales Data etc.)
4.13.1 Ironwood Pharmaceuticals, Inc  Profile
Table Ironwood Pharmaceuticals, Inc  Overview List
4.13.2 Ironwood Pharmaceuticals, Inc  Products & Services
4.13.3 Ironwood Pharmaceuticals, Inc  Business Operation Conditions
Table Business Operation of Ironwood Pharmaceuticals, Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Salix Pharmaceuticals Ltd  (Company Profile, Sales Data etc.)
4.14.1 Salix Pharmaceuticals Ltd  Profile
Table Salix Pharmaceuticals Ltd  Overview List
4.14.2 Salix Pharmaceuticals Ltd  Products & Services
4.14.3 Salix Pharmaceuticals Ltd  Business Operation Conditions
Table Business Operation of Salix Pharmaceuticals Ltd  (Sales Revenue, Cost, Gross Margin)
4.15 Norgine B.V  (Company Profile, Sales Data etc.)
4.15.1 Norgine B.V  Profile
Table Norgine B.V  Overview List
4.15.2 Norgine B.V  Products & Services
4.15.3 Norgine B.V  Business Operation Conditions
Table Business Operation of Norgine B.V  (Sales Revenue, Cost, Gross Margin)
4.16 Prometheus Laboratories Inc  (Company Profile, Sales Data etc.)
4.16.1 Prometheus Laboratories Inc  Profile
Table Prometheus Laboratories Inc  Overview List
4.16.2 Prometheus Laboratories Inc  Products & Services
4.16.3 Prometheus Laboratories Inc  Business Operation Conditions
Table Business Operation of Prometheus Laboratories Inc  (Sales Revenue, Cost, Gross Margin)
4.17 Actavis Nordic A/S  (Company Profile, Sales Data etc.)
4.17.1 Actavis Nordic A/S  Profile
Table Actavis Nordic A/S  Overview List
4.17.2 Actavis Nordic A/S  Products & Services
4.17.3 Actavis Nordic A/S  Business Operation Conditions
Table Business Operation of Actavis Nordic A/S  (Sales Revenue, Cost, Gross Margin)
4.18 Albireo Pharma Inc  (Company Profile, Sales Data etc.)
4.18.1 Albireo Pharma Inc  Profile
Table Albireo Pharma Inc  Overview List
4.18.2 Albireo Pharma Inc  Products & Services
4.18.3 Albireo Pharma Inc  Business Operation Conditions
Table Business Operation of Albireo Pharma Inc  (Sales Revenue, Cost, Gross Margin)
4.19 Yuhan Corp  (Company Profile, Sales Data etc.)
4.19.1 Yuhan Corp  Profile
Table Yuhan Corp  Overview List
4.19.2 Yuhan Corp  Products & Services
4.19.3 Yuhan Corp  Business Operation Conditions
Table Business Operation of Yuhan Corp  (Sales Revenue, Cost, Gross Margin)
4.20 Astrazeneca Plc  (Company Profile, Sales Data etc.)
4.20.1 Astrazeneca Plc  Profile
Table Astrazeneca Plc  Overview List
4.20.2 Astrazeneca Plc  Products & Services
4.20.3 Astrazeneca Plc  Business Operation Conditions
Table Business Operation of Astrazeneca Plc  (Sales Revenue, Cost, Gross Margin)
4.21 The Menarini Group  (Company Profile, Sales Data etc.)
4.21.1 The Menarini Group  Profile
Table The Menarini Group  Overview List
4.21.2 The Menarini Group  Products & Services
4.21.3 The Menarini Group  Business Operation Conditions
Table Business Operation of The Menarini Group  (Sales Revenue, Cost, Gross Margin)
4.22 Ono Pharmaceutical Co., Ltd (Company Profile, Sales Data etc.)
4.22.1 Ono Pharmaceutical Co., Ltd Profile
Table Ono Pharmaceutical Co., Ltd Overview List
4.22.2 Ono Pharmaceutical Co., Ltd Products & Services
4.22.3 Ono Pharmaceutical Co., Ltd Business Operation Conditions
Table Business Operation of Ono Pharmaceutical Co., Ltd (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global IBS-C Drugs Sales Revenue 2016-2020, by Company, in USD Million
Table Global IBS-C Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global IBS-C Drugs Sales Revenue Share in 2020, by Company, in USD Million
Table Global IBS-C Drugs Sales Volume 2016-2020, by Company, in Volume
Table Global IBS-C Drugs Sales Volume Share 2016-2020, by Company, in Volume
Figure Global IBS-C Drugs Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America IBS-C Drugs Market Concentration, in 2020
Figure Europe IBS-C Drugs Market Market Concentration, in 2020
Figure Asia-Pacific IBS-C Drugs MMarket Concentration, in 2020
Figure South America IBS-C Drugs Market Concentration, in 2020
Figure Middle East & Africa IBS-C Drugs Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital Pharmacies 
Figure IBS-C Drugs Demand in Hospital Pharmacies , 2016-2020, in USD Million
Figure IBS-C Drugs Demand in Hospital Pharmacies , 2016-2020, in Volume
6.1.2 Demand in Retail Pharmacies 
Figure IBS-C Drugs Demand in Retail Pharmacies , 2016-2020, in USD Million
Figure IBS-C Drugs Demand in Retail Pharmacies , 2016-2020, in Volume
6.1.3 Demand in Online Pharmacies
Figure IBS-C Drugs Demand in Online Pharmacies, 2016-2020, in USD Million
Figure IBS-C Drugs Demand in Online Pharmacies, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table IBS-C Drugs Demand Forecast 2021-2026, by Application, in USD Million
Figure IBS-C Drugs Market Growth 2021-2026, by Application, in USD Million
Figure IBS-C Drugs Market Share in 2026, by Application, in USD Million
Table IBS-C Drugs Demand Forecast 2021-2026, by Application, in Volume
Table IBS-C Drugs Market Growth 2021-2026, by Application, in Volume
Table IBS-C Drugs Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table IBS-C Drugs Production 2016-2020, by Region, in USD Million
Table IBS-C Drugs Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global IBS-C Drugs Market 2016-2020, by Region, in USD Million
Table Global IBS-C Drugs Market Share 2016-2020, by Region, in USD Million
Table Global IBS-C Drugs Market 2016-2020, by Region, in Volume
Table Global IBS-C Drugs Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America IBS-C Drugs Market Size and Growth 2016-2020, in USD Million
Figure North America IBS-C Drugs Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America IBS-C Drugs Market Size 2016-2020, by Country, in USD Million
Table North America IBS-C Drugs Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe IBS-C Drugs Market Size and Growth 2016-2020, in USD Million
Figure Europe IBS-C Drugs Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe IBS-C Drugs Market Size 2016-2020, by Country, in USD Million
Table Europe IBS-C Drugs Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific IBS-C Drugs Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific IBS-C Drugs Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific IBS-C Drugs Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific IBS-C Drugs Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America IBS-C Drugs Market Size and Growth 2016-2020, in USD Million
Figure South America IBS-C Drugs Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America IBS-C Drugs Market Size 2016-2020, by Country, in USD Million
Table South America IBS-C Drugs Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa IBS-C Drugs Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa IBS-C Drugs Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa IBS-C Drugs Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa IBS-C Drugs Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table IBS-C Drugs Market Forecast 2021-2026, by Region, in USD Million
Table IBS-C Drugs Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Figure

List of Table
List of Table
1. Table Upstream Segment of IBS-C Drugs
2. Table Application Segment of IBS-C Drugs
3. Table Global IBS-C Drugs Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Lubiprostone 
5. Table Major Company List of Osmotic Laxatives 
6. Table Major Company List of Stimulant Laxatives 
7. Table Major Company List of Others
8. Table Global IBS-C Drugs Market 2016-2020, by Type, in USD Million
9. Table Global IBS-C Drugs Market 2016-2020, by Type, in Volume
10. Table Global IBS-C Drugs Market Forecast 2021-2026, by Type, in USD Million
11. Table Global IBS-C Drugs Market Forecast 2021-2026, by Type, in Volume
12. Table Catalent Pharmaceuticals Solutions  Overview List
13. Table Business Operation of Catalent Pharmaceuticals Solutions  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table Nestle  Overview List
15. Table Business Operation of Nestle  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table Abbott Laboratories  Overview List
17. Table Business Operation of Abbott Laboratories  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table Synergy Pharmaceuticals  Overview List
19. Table Business Operation of Synergy Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table Sucampo Pharmaceuticals  Overview List
21. Table Business Operation of Sucampo Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table Novartis Pharma Ag  Overview List
23. Table Business Operation of Novartis Pharma Ag  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table Astellas Pharmaceuticals  Overview List
25. Table Business Operation of Astellas Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table Ardelyx, Inc  Overview List
27. Table Business Operation of Ardelyx, Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
28. Table Synthetic Biologics, Inc  Overview List
29. Table Business Operation of Synthetic Biologics, Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
30. Table Teva Pharmaceutical Industries  Overview List
31. Table Business Operation of Teva Pharmaceutical Industries  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
32. Table Bama-Geve, SLU  Overview List
33. Table Business Operation of Bama-Geve, SLU  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
34. Table Ferring BV  Overview List
35. Table Business Operation of Ferring BV  (Sales Revenue, Cost, Gross Margin)
36. Table Ironwood Pharmaceuticals, Inc  Overview List
37. Table Business Operation of Ironwood Pharmaceuticals, Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
38. Table Salix Pharmaceuticals Ltd  Overview List
39. Table Business Operation of Salix Pharmaceuticals Ltd  (Sales Revenue, Cost, Gross Margin)
40. Table Norgine B.V  Overview List
41. Table Business Operation of Norgine B.V  (Sales Revenue, Cost, Gross Margin)
42. Table Prometheus Laboratories Inc  Overview List
43. Table Business Operation of Prometheus Laboratories Inc  (Sales Revenue, Cost, Gross Margin)
44. Table Actavis Nordic A/S  Overview List
45. Table Business Operation of Actavis Nordic A/S  (Sales Revenue, Cost, Gross Margin)
46. Table Albireo Pharma Inc  Overview List
47. Table Business Operation of Albireo Pharma Inc  (Sales Revenue, Cost, Gross Margin)
48. Table Yuhan Corp  Overview List
49. Table Business Operation of Yuhan Corp  (Sales Revenue, Cost, Gross Margin)
50. Table Astrazeneca Plc  Overview List
51. Table Business Operation of Astrazeneca Plc  (Sales Revenue, Cost, Gross Margin)
52. Table The Menarini Group  Overview List
53. Table Business Operation of The Menarini Group  (Sales Revenue, Cost, Gross Margin)
54. Table Ono Pharmaceutical Co., Ltd Overview List
55. Table Business Operation of Ono Pharmaceutical Co., Ltd (Sales Revenue, Cost, Gross Margin)
56. Table Global IBS-C Drugs Sales Revenue 2016-2020, by Company, in USD Million
57. Table Global IBS-C Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
58. Table Global IBS-C Drugs Sales Volume 2016-2020, by Company, in Volume
59. Table Global IBS-C Drugs Sales Volume Share 2016-2020, by Company, in Volume
60. Table Regional Demand Comparison List
61. Table Major Application in Different Regions
62. Table IBS-C Drugs Demand Forecast 2021-2026, by Application, in USD Million
63. Table IBS-C Drugs Demand Forecast 2021-2026, by Application, in Volume
64. Table IBS-C Drugs Market Growth 2021-2026, by Application, in Volume
65. Table IBS-C Drugs Market Share in 2026, by Application, in Volume
66. Table IBS-C Drugs Production 2016-2020, by Region, in USD Million
67. Table IBS-C Drugs Production 2016-2020, by Region, in Volume
68. Table Global IBS-C Drugs Market 2016-2020, by Region, in USD Million
69. Table Global IBS-C Drugs Market Share 2016-2020, by Region, in USD Million
70. Table Global IBS-C Drugs Market 2016-2020, by Region, in Volume
71. Table Global IBS-C Drugs Market Share 2016-2020, by Region, in Volume
72. Table North America IBS-C Drugs Market Size 2016-2020, by Country, in USD Million
73. Table North America IBS-C Drugs Market Size 2016-2020, by Country, in Volume
74. Table Europe IBS-C Drugs Market Size 2016-2020, by Country, in USD Million
75. Table Europe IBS-C Drugs Market Size 2016-2020, by Country, in Volume
76. Table Asia-Pacific IBS-C Drugs Market Size 2016-2020, by Country, in USD Million
77. Table Asia-Pacific IBS-C Drugs Market Size 2016-2020, by Country, in Volume
78. Table South America IBS-C Drugs Market Size 2016-2020, by Country, in USD Million
79. Table South America IBS-C Drugs Market Size 2016-2020, by Country, in Volume
80. Table Middle East & Africa IBS-C Drugs Market Size 2016-2020, by Country, in USD Million
81. Table Middle East & Africa IBS-C Drugs Market Size 2016-2020, by Country, in Volume
82. Table IBS-C Drugs Market Forecast 2021-2026, by Region, in USD Million
83. Table IBS-C Drugs Market Forecast 2021-2026, by Region, in Volume
84. Table Price Factors List